Marshall Wace, LLP V Tv Therapeutics Inc. Transaction History

Marshall Wace, LLP

  • $72.2 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$0.95 - $1.69 $22,218 - $39,525
-23,388 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$1.53 - $2.22 $380,766 - $552,484
-248,867 Reduced 91.41%
23,388 $36,000
Q2 2021

Aug 13, 2021
BUY
$2.27 - $3.44 $216,260 - $327,725
95,269 Added 53.83%
272,255 $621,000
Q1 2021

May 17, 2021
BUY
$1.97 - $2.89 $348,662 - $511,489
176,986 New
176,986 $499,000

Others Institutions Holding VTVT

# of Institutions
1
Shares Held
243K
Call Options Held
0
Put Options Held
0
View Full List

About vTv Therapeutics Inc.

VTVT Quotes by TradingView
  • Ticker VTVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,483,600
  • Market Cap $1.1B
  • Description
  • vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...
More about VTVT
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email